兔单克隆抗体[EP700Y] to E Cadherin - Intercellular Junction Marker
宿主
Rabbit
特异性
This antibody has been tested on human samples in both WB and IHC. Customer feedback (see Abreview) suggests the antibody does not perform well in IHC on mouse tissue.
经测试应用
适用于: Flow Cyt (Intra), ICC/IF, mIHC, IHC-P, WB
种属反应性
与反应: Human
免疫原
Synthetic peptide within Human E Cadherin aa 600-700. The exact sequence is proprietary.
阳性对照
IHC-P: Human breast carcinoma, lung adenocarcinoma and colonic adenocarcinoma tissue. Human papillary carcinoma of thyroid gland and transitional cell carcinoma of kidney tissue. ICC/IF: MCF7, HT-29 and wild-type A431 cells. Flow Cyt (intra): A431 and MCF7 cells. WB: MCF-7, HT-29, HepG2 and PC-3 whole cell lysate. mIHC: Human endometrium tissue.
This product is a recombinant monoclonal antibody, which offers several advantages including:
- High batch-to-batch consistency and reproducibility
- Improved sensitivity and specificity
- Long-term security of supply
- Animal-free production
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
Rat: We have preliminary internal testing data to indicate this antibody may not react with this species. Please contact us for more information.
Zheng Y et al. LncNAP1L6 activates MMP pathway by stabilizing the m6A-modified NAP1L2 to promote malignant progression in prostate cancer. Cancer Gene Ther 30:209-218 (2023).
Song MJ et al. Bioprinted 3D outer retina barrier uncovers RPE-dependent choroidal phenotype in advanced macular degeneration. Nat Methods 20:149-161 (2023).
Xu R et al. Plectin Downregulation Inhibits Migration and Suppresses Epithelial Mesenchymal Transformation of Hepatocellular Carcinoma Cells via ERK1/2 Signaling. Int J Mol Sci 24:N/A (2022).
Wu Q et al. UBR5 promotes migration and invasion of glioma cells by regulating the ECRG4/NF-ҡB pathway. J Biosci 47:N/A (2022). WB ; Human .
Yu J et al. Dictamnine, a novel c-Met inhibitor, suppresses the proliferation of lung cancer cells by downregulating the PI3K/AKT/mTOR and MAPK signaling pathways. Biochem Pharmacol 195:114864 (2022).